Photo from wikipedia
Abstract Stereotactic ablative radiotherapy as a treatment option for stage I neuroendocrine cancer of the lung is not yet well understood. While analogs can be made to non-small cell lung… Click to show full abstract
Abstract Stereotactic ablative radiotherapy as a treatment option for stage I neuroendocrine cancer of the lung is not yet well understood. While analogs can be made to non-small cell lung cancer, high-grade neuroendocrine tumors are very radioresponsive and, therefore, present unique challenges around tumor localization. We present a case of stage I high-grade neuroendocrine lung cancer treated with SABR and the technical considerations surrounding changes in tumor location and morphology.
Keywords:
neuroendocrine cancer;
cancer lung;
ablative radiotherapy;
cancer;
stereotactic ablative;
lung
Journal Title: Advances in Radiation Oncology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Advances in Radiation Oncology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!